REQUEST A DEMO
Total
USD $0.00
Search more companies

Neotac Pharma Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: All Other Food Manufacturing | All Other Miscellaneous Food Manufacturing | Toilet Preparation Manufacturing | General Line Grocery Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Packaging and Labeling Services
Full name: Neotac Pharma Sp. z o.o. Profile Updated: May 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Neotac Pharma Sp. z o.o. is based in Poland, with the head office in Krakow. It operates in the Pharmaceutical Preparation Manufacturing industry. The enterprise was incorporated on December 18, 2019. From the latest financial highlights, Neotac Pharma Sp. z o.o. reported a net sales revenue increase of 137.77% in 2023. During that time, Neotac Pharma Sp. z o.o.’s total assets grew by 225.09%. The net profit margin of Neotac Pharma Sp. z o.o. increased by 3.56% in 2023.

Headquarters
Ul. Krolowej Jadwigi 148A/1A
Krakow; Malopolskie; Postal Code: 30-212

Contact Details: Purchase the Neotac Pharma Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Neotac Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Neotac Pharma Sp. z o.o. report to view the information.
Incorporation Date:
December 18, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
90%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Neotac Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
137.77%
Total operating revenue
130.36%
Operating profit (EBIT)
461.13%
Net Profit (Loss) for the Period
374.07%
Total assets
225.09%
Total equity
45.59%
Operating Profit Margin (ROS)
4.87%
Net Profit Margin
3.56%
Return on Equity (ROE)
21.69%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?